Clinical Trials for NASH - Nonalcoholic Steatohepatitis

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT ID: NCT06528314

This clinical trial is studying a new medication called efruxifermin (EFX) for people with compensated cirrhosis caused by nonalcoholic steatohepatitis (NASH) or metabolic dysfunction-associated st...

Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

NCT ID: NCT03587831

This clinical trial is studying the effects of two different approaches to treat Non-Alcoholic Steatohepatitis (NASH), a liver condition that can lead to serious health issues. Participants in the ...

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients with Nonalcoholic Steatohepatitis

NCT ID: NCT06195943

This clinical trial is exploring a new exercise program called Exercise and Liver FITness (EL-FIT) for people with Nonalcoholic Steatohepatitis (NASH), a condition that affects the liver. The goal ...

Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE

NCT ID: NCT04591106

Statins for the Treatment of NASH

NCT ID: NCT04679376

This clinical trial is studying the use of a medication called atorvastatin (often known by the brand name Lipitor®) to see if it can safely improve a liver condition called Nonalcoholic Steatohepa...

Nonalcoholic Fatty Liver Disease in HIV Database

NCT ID: NCT05023044

This clinical trial is looking at nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in people living with HIV. NAFLD is a condition where fat builds up in the liver, ...

Digital Therapeutic Lifestyle Intervention Program for Patients with MASLD

NCT ID: NCT06352177

The ENLIGHTEN study is looking at a new digital program designed to help people with a liver condition called MASH, which is a serious type of liver disease that can lead to more severe health issu...

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

NCT ID: NCT06623084

The iGAL-AXIS clinical trial is investigating how certain blood cells called platelets, which can be affected by substances from the gut, influence the progression of liver diseases like Non-alcoho...

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

NCT ID: NCT04232566

This clinical trial is exploring how inflammation in body fat and fat buildup around the liver may affect liver health and insulin resistance in people with obesity. Specifically, the researchers w...

Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)

NCT ID: NCT04697810

This clinical trial is studying a medication called namodenoson to see if it can help treat a liver condition known as Non-Alcoholic Steatohepatitis (NASH). NASH is when there is fat in the liver t...

Estrogen Administration for the Treatment of NASH in Postmenopausal Women

NCT ID: NCT04833140

This clinical trial is exploring the effects of estrogen, specifically a hormone called estradiol, on women who have a liver condition known as Nonalcoholic Steatohepatitis (NASH). NASH is a more s...

Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach

NCT ID: NCT04841057

Disease Prevention in Clinical Practice Base on Patient Specific Physiology

NCT ID: NCT03308773

Gut Permeability and Bariatric-metabolic Surgery

NCT ID: NCT05257200

This clinical trial is studying how bariatric (weight-loss) surgery affects the gut's ability to absorb substances and the balance of bacteria in the intestines in patients with a liver condition c...

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

NCT ID: NCT04849728

This clinical trial, called NATiV3, is studying a new treatment called lanifibranor for adults with a liver condition known as Nonalcoholic Steatohepatitis (NASH) and fibrosis stages F2 or F3. NASH...

Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement

NCT ID: NCT04781933

This clinical trial is studying the effects of a combination of dietary supplements, including probiotics, on patients with nonalcoholic steatohepatitis (NASH), a type of liver disease. The goal is...

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

NCT ID: NCT04054310

The N-QUAN trial is studying how well a non-invasive test, called CT1, can help identify patients with a liver condition known as Nonalcoholic Steatohepatitis (NASH). This trial is specifically for...

A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

NCT ID: NCT03472157

This clinical trial is studying the effects of bariatric surgery, a type of weight-loss surgery, on patients with severe nonalcoholic steatohepatitis (NASH) and advanced liver fibrosis. The goal is...

The European NAFLD Registry

NCT ID: NCT04442334

The European NAFLD Registry is a clinical study aimed at understanding Non-Alcoholic Fatty Liver Disease (NAFLD) and its more severe form, Non-Alcoholic Steatohepatitis (NASH). The study will gathe...

The Franciscus Obesity NASH Study

NCT ID: NCT05499949

The Franciscus Obesity NASH Study is a clinical research trial aimed at understanding how Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) change over time in peop...